Kisspeptin vs PT-141 (Bremelanotide)
Kisspeptin and PT-141 (Bremelanotide) are studied in overlapping research areas, which is why they are frequently compared. This is a neutral side-by-side reference drawn from published preclinical literature and laboratory handling data.
How they actually differ
Comparing the two: Kisspeptin is decapeptide (kisspeptin-10), kiss1 gene product fragment, while PT-141 (Bremelanotide) is cyclic heptapeptide, melanocortin receptor agonist — different molecular classes with different handling consequences; their leading degradation routes differ (tryptophan oxidation, accelerated by light for Kisspeptin, tryptophan photo-oxidation for PT-141 (Bremelanotide)), so the storage precautions that matter are not the same; their practical working windows differ once reconstituted. The sections below set out each in full.
Kisspeptin — origin
Kisspeptin-10 is the C-terminal decapeptide of the KISS1 gene product, active at the KISS1 receptor (GPR54). It sits at the top of the reproductive signalling axis, studied for triggering GnRH release. The parent protein was first described as a metastasis suppressor, hence the older name metastin.
PT-141 (Bremelanotide) — origin
PT-141 is a metabolite of Melanotan II, and its history is an unusually direct case of a side effect becoming the research programme. Melanotan II was developed as a synthetic α-MSH analogue for pigmentation research; an unanticipated effect observed during that work redirected attention to the metabolite, which was then developed separately as bremelanotide.
Kisspeptin research themes
Studied as the upstream trigger of GnRH release and the downstream LH and FSH signalling cascade.
Examined as the endogenous ligand for the KISS1 receptor in reproductive neuroendocrine models.
The parent KISS1 product was first characterised in cancer-metastasis research, a separate strand of the literature.
PT-141 (Bremelanotide) research themes
Acts at melanocortin receptors, with MC3R and MC4R the subtypes of research interest.
Distinguished in the literature by acting centrally, unlike vascular-mechanism compounds in adjacent research areas.
Its origin as a metabolite of a pigmentation-research compound is central to understanding its development history.
The lactam bridge restricts conformational freedom, a common strategy for improving receptor selectivity.
Kisspeptin handling
- Reach room temperature before opening.
- Keep reconstituted solution out of direct light during long bench sessions.
- Aliquot and refrigerate.
PT-141 (Bremelanotide) handling
- Protect from light at all stages.
- Standard gentle reconstitution; the constrained ring is not agitation-sensitive in the way flexible long chains are.
- Store refrigerated and aliquot rather than repeatedly sampling one vial.
Both third-party tested
Every Popular Peptides batch of Kisspeptin and PT-141 (Bremelanotide) is independently tested by HPLC and LC-MS with a published Certificate of Analysis. Enter a lot number to pull the COA for a specific vial.
Kisspeptin reference
Related comparisons
Kisspeptin and PT-141 (Bremelanotide) are supplied strictly as research chemicals for in-vitro laboratory and research use only. They are not intended for human or animal consumption, diagnostic, or therapeutic use. This comparison summarizes published preclinical literature and laboratory handling data; it is not medical advice, not a claim of efficacy, and not usage guidance.